Archivio incontri brevi
Visita il nostro canale YouTube per accedere alla registrazione del webinar.
Chromatin and Epigenetics: From Mechanisms to Execution
- Session 1: How it works and how it looks April 14, 2021
- Session 2: Single cells and their fates April 15, 2021
SinoBiological: Tools for Immunology Research
Il webinar permette di stare al passo con le più recenti esigenze della ricerca fornendo informazioni sulle novità, i protocolli e le tecniche che hanno portato a sviluppare l’ampio pannello di prodotti Sino Biological, società biotecnologica globale che opera in diverso ambiti, dalla ricerca di base, alla ricerca traslazionale e clinica coprendo numerose aree di ricerca come ad esempio l’immunologia, il cancro, l’epigenetica e le neuroscienze.
SignalChem: Emergence of New SARS-CoV-2 Variants & Resistance to Antibody Neutralization
Understanding the emerging SARS-CoV-2 variants & strategizing research around their resistance to antibody neutralization can expedite our efforts to counter the COVID19 pandemic
Cytognos: Impact of Standardized Flow Cytometry Protocols on the Diagnostic Accuracy of Acute Leukemias
Acute leukemia is a heterogeneous group of disease reflecting stem cell of origin, capacity of maturation and commitment to a specific lineage. Leukemic cells may show early or minimal differentiation and some diagnostic entities can easily be confused with others because of their atypical immunophenotype. In particular, it is well established that some stem cell, myeloid or lymphoid antigens can be expressed on poorly differentiated acute leukemia like immature blastic plasmacytoid dendritic cell neoplasm (BPDCN) and early T-cell precursor leukemia (ETP-ALL). These entities associated with a poor prognosis can be misdiagnosed as acute myeloid leukemia with minimal differentiation (AML-M0) if proper immunophenotyping panels are not routinely performed.
Many laboratories still use their own, non-standardized, laboratory developed antibody panels. In this webinar Rafik Terra will explain how the use of the EuroFlow™ standardized approach has the potential to improve the diagnostic accuracy of rare entities like BPDCN and ETP-ALL.
Rafik Terra, Ph.D in Immunology/Biomedical Sciences, has extensive experience in Clinical Flow Cytometry. Besides his current position of Scientific Director of the Flow Cytometry Laboratory at Maisonneuve Rosemont Hospital, he works as a Teacher and Guest Lecturer for a number of hospitals and for the University of Montreal (UdeM) as well as a Consultant for different companies.
Cytognos: Capabilities of the flow cytometric OX40 assay to determine specific SARS-CoV-2 T cell responses
The adaptive immune response to SARS-CoV-2 includes specific antibody and T cell responses. Based in previous experiences with other viral infections, several assays to determine the presence of antigen-specific T cells in convalescent patients or vaccinated individuals are being tested.
LUTHOR - unparalleled sensitivity in single cell sequencing
Speaker: Dr. Yvonne Goepel
Targeting Glycosylated PD-L1 to Enhance Patients’ Anti-Cancer Immune Response
Relatore: CHIA-WEI LI Ph.D. - Assistant Researcher - Ph.D. from Rutgers University
Consistent and scalable human iPSC-derived cells for research, disease modelling and HTS
Relatori: Dr Kaiser Karim, Scientist, bit.bio
Kam Dhaliwal, SVP Alliance Management, bit.bio
Strategie Farmacologiche contro SARS-CoV-2
Relatore: Stefano Rusconi, M.D. - Associato di Malattie Infettive
Dipartimento di Scienze Biomediche e Cliniche "Luigi Sacco"
Università degli Studi di Milano
CAR-T: dalla ricerca alla clinica
Relatore: Stefano Iacovelli, PhD - Responsabile Unità di Produzione e di Sviluppo Officina Farmaceutica Ospedale Pediatrico Bambino Gesù
Genetex “Pancreatic Cancer - An Insidious and Stubborn Foe".
- Anatomy and Biology of Pancreatic Cancer
- Diagnostic Modalities, Biomarkers, and Clinical Features
- Therapeutic Options and Future Directions
- GeneTex’s Pancreatic Cancer Product Catalog
The application of CRISPR gene-edited cell lines in validation and research
Relatore: Tom Holshof, Abcam’s Strategic Account Manager
Lexogen’s new solutions for universal isolation and NGS analysis of functional small RNAs with TraPR and whole transcriptome analysis in bacteria with RiboCop
Relatore: Jorge Zepeda, PhD - Application Scientist, Lexogen GmbH
Abcam incontra Expedeon: scopri tutte le innovazioni del nuovo leader in proteomica e immunologia
Relatore: Carlo Colombo, Ph.D., Prodotti Gianni srl
Reagenti per lo sviluppo di saggi immunologici su misura. Affrontare le sfide con Abcam
Relatore: Maria Sahun, Ph.D., Channel Development Specialist, Abcam
Corso di informazione e formazione anti-contagio COVID-19
Relatori: Dott. Ugo Tentolini – Dott. Claudio Pirrò
Le Nanotecnologie nell'ambito pneumologico
Relatore: Laura Pandolfi, Ph.D., IRCCS Fondazione Policlinico San Matteo
SARS-CoV-2 / COVID19 Test rapidi IgG/IgM per la ricerca di anticorpi
Relatore: Ing. Roberta Zaccone, Prodotti Gianni srl
SARS-Cov2 e COVID19: la proposta tecnico-commerciale di Prodotti Gianni
L'obiettivo del webinar è quello di aggiornare sulle novità che Prodotti Gianni propone per lo studio di SARS-CoV2 e COVID19
SARS-Cov2 and COVID19 A world problem needing a world response
Speaker:
- Ball Alexander, M.D. Senior Scientist at GeneTex
Topics:
- Origin of SARS-CoV2
- The global situation
- The biology of SARS-CoV2
- Clinical aspects of COVID19
- GeneTex's SARS-CoV2 product catalog
Nuova piattaforma FirePlex®: profilazione di biomarker di miRNA e proteine direttamente da biofluidi
Relatori:
- Maria Sahun, Ph.D., Channel Development Specialist, Abcam
- Sandra Zampieri, Ph.D., Dip. di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova
Gli Anticorpi: una risorsa per ricerca e diagnostica
Relatore: Dott.ssa Francesca Beretta, Ph.D. , Prodotti Gianni srl
La valutazione del bilancio ossidativo nelle infezioni virali
Relatore: Dr. Francesco Colombini, R & D Area - Diacron International
Anticorpi sintetici: nuova opportunità contro SARS-CoV2
Relatore: Prof. Francesco Puoci, Dipartimento di Farmacia e Scienze della Salute e della Nutrizione Università della Calabria
|
|
Il prof. Pucci in una foto tratta dall'articolo "Coronavirus, ricercatori calabresi sperimentano nuovi anticorpi sintetici per bloccare l’infezione". |
SARS-COV-2: ricerca, diagnostica
Relatore: Carlo Colombo Phd, Prodotti Gianni